TickerFacts.

Emergent BioSolutions Inc. (EBS) — Capital Expenditures

Annual figures by period end, from SEC filings.

2009-12-31: $33.29M2010-12-31: $22.10M2011-12-31: $54.03M2012-12-31: $53.84M2013-12-31: $42.02M2014-12-31: $30.67M2015-12-31: $44.81M2016-12-31: $76.20M2017-12-31: $54.80M2018-12-31: $72.10M2019-12-31: $86.90M2020-12-31: $141.90M2021-12-31: $224.10M2022-12-31: $115.80M2023-12-31: $51.60M2024-12-31: $22.90M2025-12-31: $13.80M$13.80M
2009-12-31Capital Expenditures (USD)2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$13.80M-39.7%2026-02-27From 2025-01-01
2024-12-31$22.90M-55.6%2026-02-27From 2024-01-01
2023-12-31$51.60M-55.4%2026-02-27From 2023-01-01
2022-12-31$115.80M-48.3%2025-03-04From 2022-01-01
2021-12-31$224.10M+57.9%2024-03-08From 2021-01-01
2020-12-31$141.90M+63.3%2023-12-11From 2020-01-01
2019-12-31$86.90M+20.5%2022-02-25From 2019-01-01
2018-12-31$72.10M+31.6%2021-02-19From 2018-01-01
2017-12-31$54.80M-28.1%2020-02-25From 2017-01-01
2016-12-31$76.20M+70.0%2019-02-22From 2016-01-01
2015-12-31$44.81M+46.1%2018-02-23From 2015-01-01
2014-12-31$30.67M-27.0%2017-02-28From 2014-01-01
2013-12-31$42.02M-22.0%2016-02-29From 2013-01-01
2012-12-31$53.84M-0.3%2015-03-09From 2012-01-01
2011-12-31$54.03M+144.5%2014-03-10From 2011-01-01
2010-12-31$22.10M-33.6%2013-03-08From 2010-01-01
2009-12-31$33.29M—2012-03-09From 2009-01-01